Quick Answer
Innoviva, Inc. reported R&D Expense of $30.60 million for fiscal year 2025.
Innoviva, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $30.60M | +124.1% |
| 2024 | $13.65M | -59.7% |
| 2023 | $33.92M | -18.1% |
| 2022 | $41.43M | +7093.1% |
| 2021 | $576.0K | -67.8% |
| 2020 | $1.79M | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | -100.0% |
| 2017 | $1.35M | -2.7% |
| 2016 | $1.39M | -46.8% |
| 2015 | $2.62M | -65.1% |
| 2014 | $7.50M | -17.0% |
| 2013 | $9.04M | +10.9% |
| 2012 | $8.15M | -92.1% |
| 2011 | $103.57M | +38.0% |
| 2010 | $75.07M | -3.2% |
| 2009 | $77.52M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.67M | +285.0% | +71.2% |
| June 30, 2025 | $7.98M | +211.8% | +81.6% |
| March 31, 2025 | $4.40M | +13.4% | +23.8% |
| September 30, 2024 | $3.55M | -11.0% | +38.7% |
| June 30, 2024 | $2.56M | -82.9% | -34.0% |
| March 31, 2024 | $3.88M | -69.2% | -2.8% |
| September 30, 2023 | $3.99M | -66.0% | -73.4% |
| June 30, 2023 | $14.99M | +8.0% | +19.1% |
- Innoviva, Inc. showed an increase of +124.1% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, Innoviva, Inc.’s r&d expense has declined by 60.5% (from $77.52 million to $30.60 million).
- The most recent figure is from Innoviva, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: